Legal & General Group Plc decreased its stake in Cardinal Health, Inc. (NYSE:CAH – Free Report) by 0.6% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 2,126,442 shares of the company’s stock after selling 12,123 shares during the period. Legal & General Group Plc’s holdings in Cardinal Health were worth $436,984,000 as of its most recent filing with the Securities and Exchange Commission.
Several other institutional investors and hedge funds also recently made changes to their positions in CAH. Aventura Private Wealth LLC acquired a new stake in shares of Cardinal Health in the fourth quarter valued at about $25,000. Jones Financial Companies Lllp increased its stake in shares of Cardinal Health by 198.3% in the first quarter. Jones Financial Companies Lllp now owns 21,112 shares of the company’s stock valued at $27,000 after buying an additional 14,034 shares during the period. JPL Wealth Management LLC acquired a new stake in shares of Cardinal Health in the third quarter valued at about $31,000. Turning Point Benefit Group Inc. acquired a new stake in shares of Cardinal Health in the third quarter valued at about $31,000. Finally, Cape Investment Advisory Inc. increased its stake in shares of Cardinal Health by 61.1% in the third quarter. Cape Investment Advisory Inc. now owns 211 shares of the company’s stock valued at $33,000 after buying an additional 80 shares during the period. Institutional investors and hedge funds own 87.17% of the company’s stock.
Analyst Upgrades and Downgrades
CAH has been the subject of several recent research reports. Weiss Ratings cut Cardinal Health from a “buy (b+)” rating to a “buy (b)” rating in a research note on Tuesday, May 19th. TD Cowen increased their price target on Cardinal Health from $251.00 to $255.00 and gave the company a “buy” rating in a research note on Friday, May 1st. Argus increased their price target on Cardinal Health from $232.00 to $248.00 and gave the company a “buy” rating in a research note on Wednesday, February 11th. UBS Group set a $260.00 target price on Cardinal Health and gave the company a “buy” rating in a research report on Friday, February 6th. Finally, Zacks Research upgraded Cardinal Health from a “hold” rating to a “strong-buy” rating in a research report on Thursday, February 12th. One research analyst has rated the stock with a Strong Buy rating, fifteen have given a Buy rating and two have given a Hold rating to the company. Based on data from MarketBeat.com, Cardinal Health currently has a consensus rating of “Moderate Buy” and a consensus price target of $241.80.
Cardinal Health Price Performance
Shares of Cardinal Health stock opened at $200.42 on Tuesday. Cardinal Health, Inc. has a one year low of $137.75 and a one year high of $233.60. The stock’s 50-day moving average is $204.83 and its 200 day moving average is $208.86. The firm has a market cap of $46.94 billion, a price-to-earnings ratio of 30.64, a PEG ratio of 1.19 and a beta of 0.53.
Cardinal Health (NYSE:CAH – Get Free Report) last announced its earnings results on Thursday, April 30th. The company reported $3.17 EPS for the quarter, beating the consensus estimate of $2.79 by $0.38. Cardinal Health had a negative return on equity of 92.61% and a net margin of 0.62%.The company had revenue of $60.94 billion for the quarter, compared to analyst estimates of $62.10 billion. During the same quarter in the prior year, the company earned $2.35 EPS. The firm’s revenue for the quarter was up 11.0% compared to the same quarter last year. Cardinal Health has set its FY 2026 guidance at 10.700-10.80 EPS. On average, sell-side analysts expect that Cardinal Health, Inc. will post 10.76 EPS for the current fiscal year.
Cardinal Health Increases Dividend
The company also recently declared a quarterly dividend, which will be paid on Wednesday, July 15th. Shareholders of record on Wednesday, July 1st will be issued a $0.5158 dividend. The ex-dividend date is Wednesday, July 1st. This is an increase from Cardinal Health’s previous quarterly dividend of $0.51. This represents a $2.06 annualized dividend and a yield of 1.0%. Cardinal Health’s dividend payout ratio is currently 31.19%.
Cardinal Health Company Profile
Cardinal Health is a multinational healthcare services and products company headquartered in Dublin, Ohio. Tracing its roots to the early 1970s, the company has grown into a major provider of supply chain and distribution services for the healthcare sector. Cardinal Health operates across a range of service lines that support hospitals, health systems, pharmacies, physician offices and clinical laboratories.
The company’s core activities include the wholesale distribution of branded and generic pharmaceuticals, the supply and distribution of medical-surgical products, and the provision of logistics and inventory management solutions.
Featured Articles
- Five stocks we like better than Cardinal Health
- SpaceX Gets the Attention, But These 4 Stocks Could Get the Returns
- Microsoft Stock Discount May Be Ending as AI Catalysts Build
- Apparel Earnings Winners and Losers: Ralph Lauren Takes Off
- Why Walmart, Target and TJX Got Such Different Reactions After Earnings
Want to see what other hedge funds are holding CAH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cardinal Health, Inc. (NYSE:CAH – Free Report).
Receive News & Ratings for Cardinal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardinal Health and related companies with MarketBeat.com's FREE daily email newsletter.
